Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04722042
Other study ID # 20-3022
Secondary ID R21DC018389
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 23, 2021
Est. completion date June 30, 2024

Study information

Verified date April 2024
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Purpose: Investigate monaural and binaural hearing in electric-acoustic stimulation (EAS) users with place-based versus default maps. Participants: Cochlear implant recipients and normal-hearing listeners Procedures (methods): This is a prospective, longitudinal investigation of the monaural and binaural outcomes (such as speech perception, spatial hearing, and/or subjective benefit) of cochlear implant recipients listening with different programs. The programs will incorporate different patient and device variables to determine the effect on cochlear implant recipient outcomes.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 80
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Cochlear implant participants Inclusion Criteria: - 18-80 years of age at implantation, identify English as native language, Medical Electronics (MED-EL) array recipient, and a postoperative unaided detection threshold of less than or equal to 65 decibel (dB) hearing level (HL) at 125 Hz Exclusion Criteria: - Report or present with a cognitive delay or impairment Normal-hearing controls Inclusion Criteria: - 18-80 years of age at time of testing, unaided detection thresholds of 35 dB HL or better from 500-4000 Hz, identify English as native language Exclusion Criteria: - Report or present with a cognitive delay or impairment

Study Design


Related Conditions & MeSH terms


Intervention

Other:
place-based mapping
Adjusting the electric frequency filters to align with the cochlear place frequency
default mapping
Default frequency filter assignments

Locations

Country Name City State
United States UNC ENT at Carolina Crossing Chapel Hill North Carolina

Sponsors (2)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill National Institute on Deafness and Other Communication Disorders (NIDCD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Monaural perception over time Monaural perception (e.g., word recognition in quiet) will be assessed at defined intervals (e.g., activation, and 1, 3, 6, and 12 months post-activation). Performance (e.g., percent correct) will be compared within-subject and between group over the study intervals. Up to 12 months post-activation
Primary Binaural hearing abilities over time Binaural hearing abilities (e.g., spatial release from masking) will be assessed at defined intervals (e.g., 1, 3, 6, and 12 months post-activation). Performance (e.g., percent correct) will be compared within-subject and between group over the study intervals. Up to 12 months post-activation
Secondary Perceived abilities over time Perceived abilities will be assessed with questionnaires (e.g., Speech, Spatial, and Qualities of hearing scale; SSQ) at defined intervals (e.g., activation, and 1, 3, 6, and 12 months post-activation). A subject indicates his/her perceived abilities for each question on the SSQ using a Likert scale, with a range of 0-10 (with 10 indicating better perceived abilities). Responses will be compared between group over the study intervals. Up to 12 months post-activation
See also
  Status Clinical Trial Phase
Completed NCT04222296 - Bimodal, CROS and Severe Profound Hearing Loss Study N/A
Completed NCT04577118 - The iotaSOFT Insertion System Safety Study N/A
Withdrawn NCT04041596 - Degree of Benefit From Low-Frequency Acoustic Amplification Using the Advanced Bionics Acoustic Earhook Phase 4
Completed NCT01737489 - Title: "Development and Implementation of Innovative Auditory Training Methods and Verification of These Training Methods" N/A
Completed NCT03304106 - Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population N/A
Active, not recruiting NCT03685461 - AB-Intra- and Post-Operative Measures of Auditory Function N/A
Completed NCT03515473 - Subjective and Objective Results With CI Electrode Types
Terminated NCT03025386 - Establish a Concordance Between the Mismatch Negativity Amplitude and a Score of Logatoms Discrimination N/A
Completed NCT02966379 - Hearing Preservation and Electro-acoustic Stimulation With EVO® Electrode Lead and Zebra® Sound Processor N/A
Not yet recruiting NCT05275712 - Outcome of Cochlear Implant in Assiut University
Completed NCT03202797 - Optimizing Regulation of a Cochlear Implant in Patients With Functional Contralateral Audition.
Recruiting NCT05360212 - Anatomy-based Fitting in Cochear Implant Users N/A
Not yet recruiting NCT06142682 - Dexamethasone Eluting Cochlear Implant: a Pivotal Study N/A
Recruiting NCT03886168 - Pediatric Image-Guided Cochlear Implant Programming N/A
Enrolling by invitation NCT03306082 - Image-guided Cochlear Implant Programming (IGCIP) N/A
Enrolling by invitation NCT04320251 - Tissue Growth Characterization for Cochlear Implant Users N/A
Recruiting NCT05079867 - Cochlear Trauma, Functional and Structural Preservation in Cochlear Implant Surgery
Recruiting NCT06086041 - Predictive Study on Hearing Rehabilitation After Cochlear Implant
Recruiting NCT04711538 - Role of Diagnostic Imaging in Cochlear Implant
Completed NCT01638052 - Great Auricular Nerve Block for Children Undergoing Tympanomastoid Surgery Phase 2